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Abstract 
Case report on Isolated 1q21 rearrangement 
der(20)t(1;20)(q21;p13) with telomere involvement 
of 20p in a case of longstanding myelodysplastic 
syndrome. 
Clinics 
Age and sex 
58 years old male patient. 
Previous history 
No preleukemia; no previous malignancy; no inborn 
condition of note  
Organomegaly 
No hepatomegaly, no splenomegaly, no enlarged 
lymph nodes, no central nervous system 
involvement   
Blood 
WBC: 4.3X 109/l 
HB: 7.8g/dl 
Platelets: 232X 109/l 
Blasts: 0% 
Bone marrow: Bone marrow was hypercellular with 
erythroid hyperplasia (68% erythroid precursors) 
and erythroblastic and megakaryocytic dysplasia. 
The most typical dysplastic features in the erythroid 
line were the changes in nuclear morphology 
(multinuclearity, nuclear hyperlobulation, irregular 
nuclear contours and karyorrhexis). Some of the 
erythroblasts resembled the blasts of the pure 
erythroid leukemia (large cells with deep 
cytoplasmic basophilia and oval nucleus with 
prominent nucleolus). The test of ring sideroblasts 
was positive (55%). Megakaryocytic dysplasia was 
present with hypo- or unilobulated megakaryocytes 
of all sizes. Micromegakaryocyte and dysplastic 
megakaryocytic fragments were also seen. 
Cyto-Pathology 
Classification 
Immunophenotype not done 
Rearranged Ig Tcr not done 
Pathology 
The peripheral blood morphology was characterized 
with poikilo anisocytosis and presence of single 
oxyphilic erythroblasts. Differential blood count was 
1% myelocytes, 2% metamyelocytes, 32% bands, 
27% segments, 20% lymphocytes, 17% monocytes 
and 1% eosinophils. 
Electron microscopy not done 
Diagnosis 
Refractory cytopenia with multilineage dysplasia 
and ring sideroblasts. 
Note 
Isolated 1q21 rearrangement der(20)t(1;20)(q21;p13) with 
telomere involvement of 20p in a case of longstanding 
myelodysplastic syndrome 
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The patient was hospitalized for the first time in 
January 2006 with two years history of mild anemia. 
The examinations showed: Hb 104 g/dl, WBC 
5x109/l and platelets 327x109/l. Bone marrow was 
hypercellular with dysplasia of the erythroid lineage 
presented with megaloblastic erythropoiesis. 
Conventional cytogenetic analysis revealed a 
karyotype of 46, XY,der(20)t(1;20)(q21;p13)[20]. 
The diagnosis of refractory anemia was made and the 
patient was followed-up until 2015. In this period the 
patient was in a good clinical condition and good 
quality of life maintaining hemoglobin value 
between 95 -120 g/dl without blood transfusions.  In 
October 2015 the patient was hospitalized again. 
Conventional and molecular cytogenetic analyses 
confirmed the karyotype of 
46,XY,der(20)t(1;20)(q21;p13). The diagnosis of 
refractory cytopenia with multilineage dysplasia and 
ring sideroblasts was made and the patient received 
supportive treatment with blood transfusions.  In 
February 2016 the disease progressed to a refractory 
anemia with excess of blasts-2 (14% myeloblasts in 
bone marrow) and one course of chemotherapy with 
low doses of Cytarabine (80 mg daily) was carried 
out. The patient was followed-up in a satisfactory 
clinical condition maintaining hemoglobin value 
between 75 and 80 mg/ml and myeloblasts in the 
bone marrow between 2% and 4%. 
Survival 
Date of diagnosis 01-2006 
Treatment 
Blood transfusions and chemotherapy with low 
doses of Cytarabine. 
Complete remission: no   
Treatment related death: no   
Relapse: no   
Status Alive 
Last follow up 03-2017 
Survival 
138 In March 2017 peripheral blood showed WBC 
4.3x109/l, Hb  65 g/dl, platelets 175x109/ l and 
differential blood count 1% metamyelocytes, 5% 
bands, 52% segments, 31% lymphocytes, 6% 
monocytes and 5% eosinophils. Bone marrow 
examination revealed normocellular marrow with 
trilineage dysplasia and 4% blasts.months 
Karyotype 
Sample Bone marrow 




Banding GTG banding. 
Results 
46,XY,der(20)t(1;20)(q21;p13)[33]. 
The conventional cytogenetic study revealed 
karyotype of 46,XY,der(20)t(1;20)(q21;p13)[33] 
(Fig. 1A).  
This unbalanced translocation resulted in the 
formation of a derivative chromosome, composed of 
the recipient chromosome 20 and the additional copy 
of 1q21->qter: der(20)(1qter->1q21::20p13-
>20qter). In some metaphases the translocated 
segment 1q21qter is as though attached to an intact 
chromosome 20, suggesting that the breakpoint in 
20p is sub-telomeric or telomeric (Fig.1A). 
 
Figure 1. (A) Partial G- banded karyotypes demonstrating 
derivative chromosome 20. (B) fluorescence 'in situ' 
hybridization of the derivative chromosome 20 with arm 
specific probe for 1q and 20p compared with the respective 
schematic model of its structure. 
Other molecular cytogenetics technics 
FISH examinations were carried out according to 
manufacturer's instructions, using arm specific 
probes for 1q (ASP1q) and 20p (ASP20p), sub-
telomere DNA probe for 20p (Kreatech Diagnostic, 
Leica, Germany) and telomere probe for 20p 
(Vysis/Abbott Molecular, Des Plaines, IL, USA). 
Sub-telomere DNA probe was applied 
independently and in combination with the arm 
specific probes for 1q. Images were captured and 
analyzed with epifluorecsent microscope Nicon 80i 
(Nikon corporation, Tokyo, Japan) equipped with 
CCD camera and DAPI/red/green filter set. 
Other molecular cytogenetics results 
FISH examination with ASP1q and ASP20p probes 
and combination of sub-telomere DNA probe with 
ASP for 1q showed normal sub-telomere confirmed 
the 1q trisomy and demonstrated that the additional 
copy of 1q21qter was translocated to the short arm 
of chromosome 20 (Fig 1B and 2A).  
In  two of the 55 metaphases analyzed der(20) was 
not present. One was with trisomy and the other one 
with tetrasomy of chromosome 1. FISH examination 
with both sub-telomere and telomere DNA probes 
for 20p showed normal sub-telomere and telomere 
signal patterns -  ish 
der(20)t(1;20)(q21;p13)(D20S1156x2) and ish 




Other Molecular Studies 
Isolated 1q21 rearrangement der(20)t(1;20)(q21;p13) with 
telomere involvement of 20p in a case of longstanding 
myelodysplastic syndrome 
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Technics: 
Microarray examination of the patient's bone 
marrow DNA was performed with CGH+SNP 60K 
microarray platform (OGT, Oxford, UK) according 
to the manufacturer's protocol. The hybridization of 
the reference and patient's DNA was made via 
incubation in Mai-Tai hybridization system 
(SciGene, USA) for 22-hours at 65oC. Slides were 
scanned using scanner GenePix 4400A (Molecular 
Devices, USA) and features were extracted by 
GenePixPro7 software (Molecular Devices, USA). 
The microarray patient's profile was analysed with 
CytoSure Interpret software, v 4.4.6. (OGT, Oxford, 
UK) using HG 19. 
Results: 
aCGH study found only the gain of the segment 
1q21qter and revealed no 20p losses - arr[hg] 
1q21.1q44(142,706,628-248,514,266)x3 (Fig.3 D 
and C). Both aCGH and FISH study with sub-
telomere and telomere probes indicated that the 
breakpoint in the derivative chromosome 20 is 
located in the telomere region. 
 
Figure 2. (A) Metaphase fluorescence "in situ" 
hybridization with arm specific probe for 1q (green signal) 
and 20p (red signal) demonstrating the translocation of the 
additional copy of 1q21qter to the short arm of chromosome 
20. (The derivative chromosome 20 is arrowed). (B) 
Fluorescence 'in situ' hybridization with arm specific probe 
for 1q (green signal) and 20p sub-telomere probe (red 
signal) showing two normal signals: one in the normal 
chromosome 20 and one fitting tightly to the additional copy 
of 1q21qter (arrowed). (C) Metaphase fluorescence "in situ" 
hybridization with 20p sub-telomere probe demonstrating 
two normal signals - one in the normal and one in the 
derivative chromosome 20 (arrowed). (D) Metaphase 
fluorescence "in situ" hybridization with 20p telomere probe 
demonstrating two normal signals - one in the normal and 
one in the derivative chromosome 20 (arrowed). (E) 
Ideogram and microarray CGH plot of chromosome 1 
showing a gain for the segment 1q21->qter (green shaded 
area; the breakpoint is arrowed). (F) Ideogram and 
microarray CGH plot of chromosome 20 showing no 
deletion on the p-arm. 
Comments 
Der(20)t(1;20)(q21;p13) belongs to the group of the 
unbalanced 1q12-21 translocations observed mostly 
as a second genetic event in a large spectrum of 
hematological malignances (Zamecnikova A and Al, 
Bahar S. 2013). Unbalanced 1q12-21 translocations 
affecting 20p have been reported in 10 cases: 6 with 
multiple myeloma (Fiedler et al., 1992; Taniwaki et 
al., 1994; Keung et al., 1998; Sawyer et al., 1998; 
Mohamed et al., 2007; Sawyer et al., 2014), 1 with 
acute lymphoblastic leukemia/ lymphoblastic 
lymphoma (Wan et al., 2004), 1 with diffuse large B-
cell lymphoma (Levine et al., 1985), 1 with acute 
myeloid leukemia (M7) (Yoshida et al., 2013) and 1 
with chronic myeloproliferative disorder (L'Abbate 
et al., 2015). The molecular pathogenesis of 
der(20)t(1;20)(q12-21;p13) is linked to the gain of 
1q and the losses of coding DNA from 20p. The 
presented case demonstrated that the breakpoint in 
20p could occur in telomere region as were reported 
in other 1q translocations: 3 with der(2)t(1;2)(q12-
21;q37), 2 with der(16)t(1;16)(q12-21;q24) 
(Busson-Le Coniat M et al.,1999) and 1 with 
der(12)t(1;12)(q21;p13) (La Starza R et al., 1999). 
Because of the telomere involvement of the recipient 
chromosomes these 1q12-21 translocations did not 
result in losses of coding DNA and theirs molecular 
pathogenesis is possibly linked only to the gain of 
1q. We supposed that in our case the missing of 20p 
losses as well as additional anomalies in the 
karyotype are the reasons for the long survival of the 
patient. 
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